| 注册
首页|期刊导航|安徽医科大学学报|吉西他滨耐药的胰腺癌SW1990细胞株的建立及相关特性检测

吉西他滨耐药的胰腺癌SW1990细胞株的建立及相关特性检测

贾一夫 丁飞 余跃 高萌 杨显珠 王均

安徽医科大学学报Issue(4):419-422,4.
安徽医科大学学报Issue(4):419-422,4.

吉西他滨耐药的胰腺癌SW1990细胞株的建立及相关特性检测

Establishment of the human resistant pancreatic cancer cell lines SW1990/gemcitabine and its characteristics test

贾一夫 1丁飞 1余跃 1高萌 1杨显珠 2王均2

作者信息

  • 1. 安徽医科大学附属省立医院消化内科,合肥 230001
  • 2. 中国科学技术大学生命科学学院合肥微尺度物质科学国家实验室,合肥 230027
  • 折叠

摘要

Abstract

Objective To investigate how to induce the resistant cell line SW1990/gemcitabine( GEM) for further clarify the resistant mechanisms of pancreatic cancer , and compare the characteristics between SW1990 and SW1990-GZ. Methods SW1990-GZ was derived from the human pancreatic cancer cell lines SW1990 by exposing the cells to intermittently increasing concentrations of GEM. The IC50 ,resistance index( R) , and growth difference was observed by MTT assay. Cellular intake of SW1990 and SW1990-GZ was detection by HPLC. Results The IC50 of SW1990 and SW1990-GZ were respectively (0. 07 ± 0. 002 1)μg/ml,(87. 50 ± 3. 240 0)μg/ml,R=1 250;sensibility to GEM in SW1990-GZ were more lower than that in SW1990 cell in different concentration s of GEM. Growth rate of SW1990-GZ was slower than that of SW1990 from the growth curve;GEM intake in SW1990-GZ was lower than that in SW1990 in different times. Conclusion Human resistant pancreatic cancer cell lines SW1990/GEM is successfully established,and its resistant characteristics are stable and clear. SW1990-GZ maybe decrease GEM intake by some unclear pathways.

关键词

人类胰腺癌细胞株/吉西他滨耐药/建立

Key words

human pancreatic cancer cell lines/gemcitabine resistance/establish

分类

医药卫生

引用本文复制引用

贾一夫,丁飞,余跃,高萌,杨显珠,王均..吉西他滨耐药的胰腺癌SW1990细胞株的建立及相关特性检测[J].安徽医科大学学报,2015,(4):419-422,4.

基金项目

安徽省自然科学基金(编号:1208085MH174) (编号:1208085MH174)

安徽医科大学学报

OA北大核心CSTPCD

1000-1492

访问量4
|
下载量0
段落导航相关论文